One driver is the introduction of drugs targeting unmet needs. The heart failure (HF) sector across the seven major markets ...

The company says the early trial of its androgenic alopecia therapy saw patients benefit from six times more hair growth than ...

Bakery major Flowers Foods is adding to its presence in snacks with the acquisition of US biscuit and snack-bar maker Simple Mills for $795m.

Licensing deals have risen in prominence in a restrained market environment. Is it desperation, or an important part of the ...

ISM5411 was well tolerated and demonstrated a favourable pharmokinetic profile in validating gut-restrictive properties.

With clinical trials facing multiple challenges, digital solutions could provide the answer. We identify the key trends to watch in 2025.

In December 2024, Western Europe’s PV selling rate continued its upward trend, reaching 13.1 million units/year. Year-on-year ...

UK consumers are anticipated to incur more than £1.8bn ($2.25bn) in grid constraint payments by 2025, as reported by Bloomberg.

GlobalData has named heart failure as the next disease to feel the sales-boosting power of GLP-1 drugs. The analysts expect ...

Data from the largest US Lyme disease registry suggests that 90% of PLD patients are excluded from clinical trials.

Novartis has announced that its intrathecal (IT) formulation of onasemnogene abeparvovec (OAV101 IT) achieved the primary ...

Novartis has recently announced that its intrathecal (IT) formulation of onasemnogene abeparvovec (OAV101 IT) successfully ...